Identification of a small molecule that inhibits Pks13 with anti-tuberculosis activity
Microbiology Spectrum · 11.11.2026
DOI: 10.1128/spectrum.00786-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, online erschienen am 11.11.2026. Verfasst von Xiao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chi…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation, National Key Research and Development Program of China.
Abstract (Originalsprache)
The persistent spread of multidrug-resistant and extensively drug-resistant tuberculosis (TB) necessitates the development of novel anti-TB agents characterized by high efficacy and innovative mechanisms of action. Polyketide synthase 13 (Pks13), a vital protein in the mycolic acid biosynthetic pathway, serves as a valuable target for TB therapy due to its exclusive presence in the genus Mycobacterium . This study identified a compound, B-AP15, that potently inhibited the activity of the Pks13 thioesterase domain (Pks13-TE), giving an IC 50 of 22.48 μM. The binding interaction between B-AP15 and Pks13-TE was corroborated via surface plasmon resonance (SPR) analysis and molecular docking. Furthermore, site-directed mutagenesis, SPR analysis, and inhibitory activity assays of mutant enzymes revealed that residues H1664 and Q1633 likely serve as key binding residues for the interaction between B-AP15 and Pks13-TE. Additionally, B-AP15 exerted an inhibitory effect on Mycobacterium tuberculosis and potential intracellular anti-TB efficacy in macrophages similar to that of first-line anti-TB drugs. The higher minimum inhibitory concentration of B-AP15 for M. marinum strain overexpressing Pks13 confirmed that Pks13 is likely the target of this compound. Collectively, this study identified a Pks13 inhibitor, B-AP15, which exhibits considerable potential as a lead compound for anti-TB therapy. IMPORTANCE The spread of drug-resistant tuberculosis (TB) urgently requires new anti-TB drugs with novel mechanisms. Pks13, a key enzyme in the mycolic acid biosynthetic pathway, is an attractive therapeutic target. We identified B-AP15 as a potent Pks13 inhibitor with a distinct scaffold from previously reported Pks13 inhibitors. B-AP15 directly binds Pks13 and exhibits in vitro and intracellular anti-TB activity comparable to first-line anti-TB drugs, with promising activity especially against drug-resistant Mycobacterium tuberculosis . This study provides a promising lead compound for developing anti-TB agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Bei…
- Department of Pharmacology, Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
- Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Chinese Academy of Medical Sciences Key Laboratory of Anti-DR TB Innovative Drug Research, Institute of Materia Medica, Chinese Academy o…
ORCID-Profile: Xiao Wang, Yishuang Liu
Förderung
- Beijing Natural Science Foundation
- National Key Research and Development Program of China
Zitieren
APA
Wang, X., Liu, T., Wang, B., Zhang, W., Zhang, D., Tao, Y., Wang, Q., & Liu, Y. (2026). Identification of a small molecule that inhibits Pks13 with anti-tuberculosis activity. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00786-26
Vancouver
Wang X, Liu T, Wang B, Zhang W, Zhang D, Tao Y, et al. Identification of a small molecule that inhibits Pks13 with anti-tuberculosis activity. Microbiology Spectrum. 2026. doi:10.1128/spectrum.00786-26
BibTeX
@article{Wang2026,
author = {Wang, Xiao and Liu, Tianjiu and Wang, Bin and Zhang, Weiyan and Zhang, Dongfeng and Tao, Yuehua and Wang, Qian and Liu, Yishuang},
title = {Identification of a small molecule that inhibits Pks13 with anti-tuberculosis activity},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.00786-26}
}
EUVIMED